63 related articles for article (PubMed ID: 1316782)
21. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
Dunne SL; Bajzer Z; Vuk-Pavlović S
Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
Kost ER; Mutch DG; Herzog TJ
Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
[TBL] [Abstract][Full Text] [Related]
25. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
[TBL] [Abstract][Full Text] [Related]
26. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment.
Qu XJ; Yang JL; Russell PJ; Goldstein D
J Urol; 2004 Aug; 172(2):733-8. PubMed ID: 15247772
[TBL] [Abstract][Full Text] [Related]
27. Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha.
Salminen E; Kankuri M; Nuutila J; Lilius EM; Pellimiemi TT
Anticancer Res; 2001; 21(3B):2049-55. PubMed ID: 11497297
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma induced cell death in a cultured human salivary gland cell line.
Wu AJ; Chen ZJ; Tsokos M; O'Connell BC; Ambudkar IS; Baum BJ
J Cell Physiol; 1996 May; 167(2):297-304. PubMed ID: 8613471
[TBL] [Abstract][Full Text] [Related]
29. Beta 1 integrin expression on human small cell lung cancer cells.
Feldman LE; Shin KC; Natale RB; Todd RF
Cancer Res; 1991 Feb; 51(4):1065-70. PubMed ID: 1705164
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins.
Platanias LC; Pfeffer LM; Cruciani R; Colamonici OR
J Immunol; 1993 Apr; 150(8 Pt 1):3382-8. PubMed ID: 8468477
[TBL] [Abstract][Full Text] [Related]
31. Demonstration and partial characterization of the interferon-gamma receptor on human B lymphocytes.
Nakagawa T; Nakagawa N; Delsing GA; Volkman D; Kehrl JH
J Cell Biochem; 1989 Aug; 40(4):417-30. PubMed ID: 2528554
[TBL] [Abstract][Full Text] [Related]
32. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity.
Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB
Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
Hancock WW; Muller WA; Cotran RS
J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro].
Haraguchi S; Koide Y; Matsuo T; Yoshida TO
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3236-43. PubMed ID: 2946265
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
Eid P; Tovey MG
J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
[TBL] [Abstract][Full Text] [Related]
37. [Expression of interferon alpha receptors in cell lines from human tumors. Relationship with the antiproliferative effect].
Perea SE; Gerónimo H; López Saura P
Acta Cient Venez; 1993; 44(1):22-7. PubMed ID: 8154235
[TBL] [Abstract][Full Text] [Related]
38. Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha/beta genes in acute leukemia cell lines suggests selection against the IFN system.
Colamonici OR; Domanski P; Platanias LC; Diaz MO
Blood; 1992 Aug; 80(3):744-9. PubMed ID: 1386261
[TBL] [Abstract][Full Text] [Related]
39. Expression of the IFN alpha receptor in hairy cell leukaemia.
Platanias LC; Pfeffer LM; Barton KP; Vardiman JW; Golomb HM; Colamonici OR
Br J Haematol; 1992 Nov; 82(3):541-6. PubMed ID: 1486034
[TBL] [Abstract][Full Text] [Related]
40. Interferon receptors on the surface of interferon-sensitive and interferon-resistant urothelial carcinomas.
Grups JW; Bange FC
Urol Res; 1990; 18(2):119-22. PubMed ID: 2140214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
